`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`SYNGENTA CROP PROTECTION AG,
`Petitioner,
`
`v.
`
`UPL LTD,
`Patent Owner.
`
`
`
`
`
`Case PGR2023-00017
`Patent 11,445,727
`
`
`
`
`
`
`DECLARATION OF CAIO PRATES OF
`SYNGENTA CROP PROTECTION AG
`
`SYNGENTA EXHIBIT 1020
`Syngenta v. UPL, PGR2023-00017
`
`
`
`
`I, Caio Prates, hereby declare as follows:
`
`Case PGR2023-00017
`U.S. Patent No. 11,445,727
`
`1.
`
`My name is Caio Prates and I am an employee of Syngenta Crop
`
`Protection AG, where I have worked for almost 12 years. My current position is
`
`Fungicides Technical Manager at Syngenta Crop Protection AG, São Paulo, Brazil.
`
`2.
`
`I make this declaration based upon personal knowledge. I am over the age
`
`of 21 and otherwise competent to make this declaration.
`
`3.
`
`My responsibilities at Syngenta Corp Protection AG (“Syngenta”) are
`
`management of the fungicide team and also being responsible for new fungicides
`
`development. This involves a lot trials and methods involved in testing chemical
`
`compounds to determine if they exhibit relevant fungicidal activity.
`
`4.
`
`Syngenta attempted to duplicate the tests in U.S. Patent 11,445,727, as
`
`well as other combinations claimed in the ’727 Patent. The protocol was as
`
`follows.
`
`Field Test – 1 (2020/2021)
`
`5.
`
`A field test was prepared with the following materials and methods:
`
`Varieties:
` M8372 IPRO, NS7667 IPRO, NA5909 RR
`
`Trial Design:
`Compl. rand. Blocks in 4 reps; plot size 18 m²
`
`Equipment:
`Backpack: 150L/ha, flat nozzle, 30 lbs.
`
`
`
`
`- 2 -
`
`
`
`
`
`Case PGR2023-00017
`U.S. Patent No. 11,445,727
`
`Application Timing:
`A – Canopy pre closure (42 DAE of average)
`B – 14 days after application A
`C – 14 days after application B
`
`Assessment:
`% Severity – at 0, 7, 14, 21, 28, 35, 42 and 49 DAAA
`% Phytotoxicity – 7, 14 Days after all applications
`% Defoliation
`Yield (kg/ha)
`
`6.
`
`The trial program is summarized in Table 1.
`
`Table 1
`
`
`Place (Brazil)
`
`Variety
`
`Planting
`Date
`
`Target
`
`Area 1
`
`M 8372 IPRO Dec-08-2020 P. pachyrhizi
`
`Area 2
`
`NS7667 IPRO Nov-25-2020 P. pachyrhizi
`
`Area 3
`
`NA 5909 RR Dec-21-2020 P. pachyrhizi
`
`Area 4
`
`M 8372 IPRO Dec-05-2020 P. Pachyrhizi
`
`#
`
`1
`
`2
`
`3
`
`4
`
`
`** Trial 4 contained E. Piffusa as an additional target.
`
`
`7.
`
`Treatments were applied as described in Table 2, below. Solo applications
`
`(A1-A3 and A5-A7) were used to calculated synergy.
`
`
`
`- 3 -
`
`
`
`Case PGR2023-00017
`U.S. Patent No. 11,445,727
`
`% Control
`
`36
`65
`48
`
`74
`
`55
`71
`55
`
`79
`
`75
`
`74
`
`Rate
`(g a.i./ha)
`30
`70
`900
`30
`70
`900
`200
`150
`1500
`200
`150
`1500
`33.8
`+
`67.5
`900
`30
`+
`70
`+
`900
`
`Active
`#
`Ingredient
`A1 Benzovindiflupyr
`A2 Prothioconazole
`A3
`Mancozeb
`Benzovindiflupyr
`A4
`Prothioconazole
`
`Mancozeb
`A5 Benzovindiflupyr
`A6 Prothioconazole
`A7
`Mancozeb
`Benzovindiflupyr
`A8
`Prothioconazole
`
`Mancozeb
`Benzovindiflupyr
`+
`Prothioconazole
`Mancozeb
`Benzovindiflupyr
`+
`Prothioconazole
`+
`Mancozeb
`
`A9
`
`A10
`
`Table 3 summarizes results of the testing.
`
`- 4 -
`
`
`Table 2
`
`
`
`8.
`
`
`
`
`
`
`
`
`
`
`Table 3
`
`#
`
`Active
`Ingredient
`
`A4
`
`A9
`
`A10
`
`A8
`
`Benzovindiflupyr
`+
`Prothioconazole
`+
`Mancozeb
`Benzovindiflupyr
`+
`Prothioconazole
`+
`Mancozeb
`Benzovindiflupyr
`+
`Prothioconazole
`+
`Mancozeb
`Benzovindiflupyr
`+
`Prothioconazole
`+
`Mancozeb
`
`Isolated
`A.I. %
`Control for
`Expected
`Action
`Calculation
`36
`
`64
`
`48
`36
`
`64
`
`48
`
`36
`
`64
`
`48
`55
`
`71
`
`55
`
`Rate
`g a.i
`/ha
`
`30
`+
`70
`+
`900
`33.8
`+
`67.5
`+
`900
`30
`+
`70
`+
`900
`200
`+
`150
`+
`1500
`
`Case PGR2023-00017
`U.S. Patent No. 11,445,727
`
`Expected
`Action
`(by
`Colby)
`
`Rust
`(%Control
`Observed)
`
`Difference
`Between
`Observed
`and
`Expected
`
`89
`
`74
`
`-15
`
`89
`
`75
`
`-14
`
`89
`
`74
`
`-15
`
`94
`
`79
`
`-15
`
`
`
`- 5 -
`
`
`
`Case PGR2023-00017
`U.S. Patent No. 11,445,727
`
`Field Test – 2 (2021/2022)
`
`9.
`
`A field test was prepared with the following materials and methods:
`
`Varieties:
` M 7739, NA 5909, HO Aporé and M 8372
`
`Trial Design:
`
`Compl. rand. Blocks in 4 reps; plot size 18 m²
`
`Equipment:
`
`Backpack: 150L/ha, flat nozzle, 30 lbs.
`
`Application Timing:
`
`A – Canopy pre closure (42 DAE of average)
`
`B – 14 days after application A
`
`C – 14 days after application B
`
`Assessment:
`
`% Severity – at 0, 7, 14, 21, 28, 35, 42 and 49 DAAA
`
`% Phytotoxicity – 7, 14 Days after all applications
`% Defoliation
`Yield (kg/ha)
`
`
`
`The trial program is summarized in Table 4.
`
`
`
`- 6 -
`
`
`10.
`
`
`
`
`
`
`
`Case PGR2023-00017
`U.S. Patent No. 11,445,727
`
`Table 4
`
`
`
`# Place (Brazil) Variety
`
`Planting
`Date
`
`Target
`
`1
`
`2
`
`3
`
`4
`
`Area 4
`
`M 7739 Dec-03-2021 P. pachyrhizi
`
`Area 5
`
`NA 5909 Dec-22-2021 P. pachyrhizi
`
`Area 6
`
`HO Aporé Dec-29-2021 P. pachyrhizi
`
`Area 7
`
`M 8372 Dec-01-2021 P. Pachyrhizi
`
`11.
`
`Treatments were applied as described in Table 5, below. Solo applications
`
`(B1-B6) were used to calculated synergy.
`
`
`
`
`
`
`
`- 7 -
`
`
`
`Case PGR2023-00017
`U.S. Patent No. 11,445,727
`
`% Control
`
`55
`67
`55
`54
`61
`52
`
`69
`
`69
`
`76
`
`76
`
`Rate
`(g a.i./ha)
`30
`70
`45
`75
`1125
`60
`30
`+
` 60
`1125
`30
` +
`45
` +
`75
`1125
`33.8
`+
`67.5
`1125
`30
`70
`1125
`
`Active
`#
`Ingredient
`B1 Benzovindiflupyr
`B2
`Prothioconazole
`B3
`Cyproconazole
`B4
`Difenoconazole
`B5
`Mancozeb
`B6
`Azoxystrobin
`Benzovindiflupyr
`+
`Azoxystrobin
`Mancozeb
`Benzovindiflupyr
`+
`Cyproconazole
` +
`Difenoconazole
`Mancozeb
`Benzovindiflupyr
` +
`Prothioconazole
`Mancozeb
`
`Benzovindiflupyr
`
`B10 Prothioconazole
`
`Mancozeb
`
`
`
`B9
`
`B7
`
`
`
`B8
`
`Table 5
`
`
`
`12.
`
`Table 6 summarizes results of the testing.
`
`
`
`- 8 -
`
`
`
`Table 6
`
`#
`
`Active
`Ingredient
`
`B7
`
`B8
`
`B9
`
`B10
`
`Benzovindiflupyr
`+
`Azoxystrobin
`+
`Mancozeb
`Benzovindiflupyr
`+
`Cyproconazole
`+
`Difenoconazole
`+
`Mancozeb
`Benzovindiflupyr
`+
`Prothioconazole
`+
`Mancozeb
`Benzovindiflupyr
`+
`Prothioconazole
`+
`Mancozeb
`
`Isolated
`A.I. %
`Control for
`Expected
`Action
`Calculation
`55
`
`52
`
`61
`55
`
`55
`
`53
`
`61
`55
`
`67
`
`61
`55
`
`67
`
`61
`
`Rate
`g a.i
`/ha
`
`30
`+
`60
`+
`1125
`30
`+
`45
`+
`75
`+
`1125
`33.8
`+
`67.5
`+
`1125
`30
`+
`70
`+
`1125
`
`Case PGR2023-00017
`U.S. Patent No. 11,445,727
`
`Expected
`Action
`(by
`Colby)
`
`Rust
`(%Control
`Observed)
`
`Difference
`Between
`Observed
`and
`Expected
`
`92
`
`69
`
`-23
`
`96
`
`69
`
`-27
`
`94
`
`76
`
`-18
`
`94
`
`76
`
`-18
`
`
`
`- 9 -
`
`
`
`Case PGR2023-00017
`U.S. Patent No. 11,445,727
`
`13.
`
`This data is a true and correct representation of the results of internal
`
`testing.
`
`14.
`
`I have reviewed the data shown above and confirm that the were tested
`
`using the process described above. I can also confirm that the disease control
`
`percent observed was insufficient to meet the synergy as defined by the Colby
`
`Formula.
`
`15.
`
`I recognize that in providing this Declaration, it may be used as evidence in
`
`the above-captioned proceeding. I accordingly agree to appear for cross-
`
`examination within the scope of this Declaration and at a convenient time should
`
`the same be requested.
`
`16.
`
`I declare under penalty of perjury under the laws of the United States of
`
`America that the foregoing is true and correct.
`
`
`
`
`
`- 10 -
`
`
`
`Case PGR2023-00017
`U.S. Patent No. 11,445,727
`
`January 30, 2023
`Date:
`São Paulo, Brazil
`City/State Country
`if outside of the US
`
`At:
`
`Signature:
`
`Caio Barbosa Prates
`CPD Fungicide Manager Brazil
`Syngenta Crop Protection AG
`
`